Zimmer Biomet Stock Price, News & Analysis (NYSE:ZBH)

$113.54 0.03 (0.03 %)
(As of 12/13/2017 02:16 AM ET)
Previous Close$113.51
Today's Range$113.39 - $114.46
52-Week Range$100.81 - $133.49
Volume1.59 million shs
Average Volume1.36 million shs
Market Capitalization$22.96 billion
P/E Ratio14.05
Dividend Yield0.85%
Beta1.15

About Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet logoZimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

Receive ZBH News and Ratings via Email

Sign-up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorMedical
SymbolNYSE:ZBH
CUSIPN/A
Phone574-267-6131

Debt

Debt-to-Equity Ratio0.88%
Current Ratio1.47%
Quick Ratio0.78%

Price-To-Earnings

Trailing P/E Ratio14.05
Forward P/E Ratio14.14
P/E Growth1.76

Sales & Book Value

Annual Sales$7.68 billion
Price / Sales2.99
Cash Flow$13.40 per share
Price / Cash8.47
Book Value$48.28 per share
Price / Book2.35

Profitability

Trailing EPS$3.18
Net Income$305.90 million
Net Margins8.36%
Return on Equity16.29%
Return on Assets6.17%

Miscellaneous

Employees18,500
Outstanding Shares202,470,000

Zimmer Biomet (NYSE:ZBH) Frequently Asked Questions

What is Zimmer Biomet's stock symbol?

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

How often does Zimmer Biomet pay dividends? What is the dividend yield for Zimmer Biomet?

Zimmer Biomet announced a quarterly dividend on Monday, August 7th. Shareholders of record on Friday, September 22nd will be given a dividend of $0.24 per share on Friday, October 27th. This represents a $0.96 annualized dividend and a yield of 0.85%. The ex-dividend date is Thursday, September 21st. View Zimmer Biomet's Dividend History.

How were Zimmer Biomet's earnings last quarter?

Zimmer Biomet Holdings Inc (NYSE:ZBH) posted its quarterly earnings data on Wednesday, November, 1st. The medical equipment provider reported $1.72 earnings per share for the quarter, missing analysts' consensus estimates of $1.74 by $0.02. The medical equipment provider earned $1.82 billion during the quarter, compared to analyst estimates of $1.83 billion. Zimmer Biomet had a return on equity of 16.29% and a net margin of 8.36%. Zimmer Biomet's revenue was down .8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.79 EPS. View Zimmer Biomet's Earnings History.

When will Zimmer Biomet make its next earnings announcement?

Zimmer Biomet is scheduled to release their next quarterly earnings announcement on Monday, January, 29th 2018. View Earnings Estimates for Zimmer Biomet.

What guidance has Zimmer Biomet issued on next quarter's earnings?

Zimmer Biomet updated its FY17 earnings guidance on Wednesday, November, 1st. The company provided earnings per share guidance of $8.01-$8.07 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $8.23. The company issued revenue guidance of $7.76-$7.80 billion, compared to the consensus revenue estimate of $7.83 billion.Zimmer Biomet also updated its Q4 guidance to $2.08-$2.14 EPS.

Where is Zimmer Biomet's stock going? Where will Zimmer Biomet's stock price be in 2017?

22 equities research analysts have issued 1-year price objectives for Zimmer Biomet's shares. Their predictions range from $92.00 to $158.00. On average, they expect Zimmer Biomet's share price to reach $135.75 in the next twelve months. View Analyst Ratings for Zimmer Biomet.

What are Wall Street analysts saying about Zimmer Biomet stock?

Here are some recent quotes from research analysts about Zimmer Biomet stock:

  • 1. According to Zacks Investment Research, "Zimmer Biomet ended the third quarter 2017 on a dismal note with earnings below the Zacks Consensus Estimate and revenues in line with the same. Sales were declining within most of the core segments primarily due to the slower pace of supply recovery and sales recapture of certain key brands particularly in the United States and softened domestic market conditions. The lowered 2017 guidance also added to our concerns indicating little chances of recovery ahead. Over, the last three months, the company has been observed to trade below the broader industry. Nevertheless, we look forward to the expected synergy from the LDR Holding acquisition, which should broaden and complement the company's musculoskeletal offering. We are also impressed by the strong strategic and financial goals which the combined entity expects to reach, now that the deal has been closed." (11/20/2017)
  • 2. Canaccord Genuity analysts commented, "SGEN reported 1Q earnings and provided a pipeline update." (4/28/2017)
  • 3. Needham & Company LLC analysts commented, "We hosted a dinner and investor meetings with Dan Florin, Senior Vice President and CFO, and Bob Marshall, Treasurer and Vice President of Investor Relations this week in New York City. We think that the discussion was upbeat and highlighted ZBH's progress in addressing its manufacturing challenges, its non-recon business performance, margin opportunities, and cash flow outlook. The meetings reinforced our view that ZBH should be able to drive its revenue growth to sustainable mid-single digit growth with a combination of market growth in recon and above-market growth in its non-recon businesses. We reiterate our Strong Buy rating." (2/17/2017)

Who are some of Zimmer Biomet's key competitors?

Who are Zimmer Biomet's key executives?

Zimmer Biomet's management team includes the folowing people:

  • Daniel P. Florin, Interim Chief Executive Officer, Chief Financial Officer, Director (Age 53)
  • Robert D. Delps, President, Americas
  • Katarzyna Mazur-Hofsaess M.D. Ph.D., President, Europe, Middle East and Africa (Age 52)
  • Sang Yi, President, Asia Pacific (Age 54)
  • Chad F. Phipps, Senior Vice President, General Counsel, Secretary (Age 44)
  • Larry C. Glasscock, Independent Non-Executive Chairman of the Board (Age 69)
  • Christopher B. Begley, Independent Director (Age 65)
  • Betsy J. Bernard, Independent Director (Age 61)
  • Gail Koziara Boudreaux, Independent Director (Age 56)
  • Michael Farrell, Independent Director (Age 45)

Who owns Zimmer Biomet stock?

Zimmer Biomet's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Longview Partners Guernsey LTD (3.71%), Nordea Investment Management AB (2.61%), Jana Partners LLC (2.30%), American Century Companies Inc. (2.06%), Bank of New York Mellon Corp (1.36%) and Ameriprise Financial Inc. (1.23%). Company insiders that own Zimmer Biomet stock include Blackstone Capital Partners V, Chad F Phipps, Daniel E Williamson, Daniel P Florin, David A Jr Nolan, David C Dvorak, Sang Yi, Stuart G Kleopfer and Tony W Collins. View Institutional Ownership Trends for Zimmer Biomet.

Who sold Zimmer Biomet stock? Who is selling Zimmer Biomet stock?

Zimmer Biomet's stock was sold by a variety of institutional investors in the last quarter, including Investec Asset Management LTD, Ameriprise Financial Inc., Sterling Capital Management LLC, Boston Partners, Korea Investment CORP, Neuberger Berman Group LLC, Russell Investments Group Ltd. and First Manhattan Co.. Company insiders that have sold Zimmer Biomet company stock in the last year include Chad F Phipps, David C Dvorak, Sang Yi and Tony W Collins. View Insider Buying and Selling for Zimmer Biomet.

Who bought Zimmer Biomet stock? Who is buying Zimmer Biomet stock?

Zimmer Biomet's stock was bought by a variety of institutional investors in the last quarter, including Longview Partners Guernsey LTD, Alyeska Investment Group L.P., Jana Partners LLC, Bank of New York Mellon Corp, Cramer Rosenthal Mcglynn LLC, Wells Fargo & Company MN, Nordea Investment Management AB and American Century Companies Inc.. View Insider Buying and Selling for Zimmer Biomet.

How do I buy Zimmer Biomet stock?

Shares of Zimmer Biomet can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Zimmer Biomet's stock price today?

One share of Zimmer Biomet stock can currently be purchased for approximately $113.54.

How big of a company is Zimmer Biomet?

Zimmer Biomet has a market capitalization of $22.96 billion and generates $7.68 billion in revenue each year. The medical equipment provider earns $305.90 million in net income (profit) each year or $3.18 on an earnings per share basis. Zimmer Biomet employs 18,500 workers across the globe.

How can I contact Zimmer Biomet?

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The medical equipment provider can be reached via phone at 574-267-6131 or via email at [email protected]


MarketBeat Community Rating for Zimmer Biomet (ZBH)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  558 (Vote Outperform)
Underperform Votes:  430 (Vote Underperform)
Total Votes:  988
MarketBeat's community ratings are surveys of what our community members think about Zimmer Biomet and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Zimmer Biomet (NYSE:ZBH) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.692.692.732.76
Ratings Breakdown: 1 Sell Rating(s)
7 Hold Rating(s)
17 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
17 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
18 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
18 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $136.74$136.82$139.26$133.16
Price Target Upside: 20.43% upside23.37% upside24.03% upside6.38% upside

Zimmer Biomet (NYSE:ZBH) Consensus Price Target History

Price Target History for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE:ZBH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/12/2017BMO Capital MarketsReiterated RatingBuy$142.00LowView Rating Details
11/14/2017Deutsche BankUpgradeHold -> Buy$128.00N/AView Rating Details
11/9/2017Edward JonesUpgradeHold -> BuyN/AView Rating Details
11/7/2017Royal Bank of CanadaLower Price TargetOutperform$125.00N/AView Rating Details
11/3/2017Stifel NicolausReiterated RatingHold$120.00N/AView Rating Details
11/3/2017Jefferies GroupReiterated RatingBuy$136.00N/AView Rating Details
11/2/2017Morgan StanleyLower Price TargetOverweight$146.00 -> $136.00N/AView Rating Details
11/2/2017Piper Jaffray CompaniesDowngradeOverweight -> NeutralN/AView Rating Details
11/1/2017SunTrust BanksSet Price TargetBuy$136.00N/AView Rating Details
8/24/2017GabelliInitiated CoverageBuy$142.00LowView Rating Details
8/14/2017OppenheimerSet Price TargetBuy$137.00LowView Rating Details
7/28/2017Leerink SwannBoost Price TargetOutperform$141.00 -> $146.00LowView Rating Details
7/28/2017Canaccord GenuityDowngradeBuy -> Hold$141.00 -> $135.00MediumView Rating Details
7/27/2017Cantor FitzgeraldSet Price TargetHold$137.00LowView Rating Details
7/14/2017Bank of AmericaReiterated RatingBuy -> Buy$158.00MediumView Rating Details
7/14/2017Wells Fargo & CompanyReiterated RatingMarket WeightHighView Rating Details
7/12/2017Needham & Company LLCReiterated RatingStrong-Buy$153.00LowView Rating Details
7/12/2017GuggenheimUpgradeNeutral -> Buy$157.00MediumView Rating Details
6/9/2017CitigroupBoost Price TargetNeutral$108.00 -> $130.00LowView Rating Details
5/16/2017Goldman Sachs GroupInitiated CoverageSell -> Sell$92.00HighView Rating Details
2/1/2017Robert W. BairdReiterated RatingOutperform$130.00 -> $136.00N/AView Rating Details
1/5/2017J P Morgan Chase & CoSet Price TargetBuy$134.00N/AView Rating Details
11/8/2016Northcoast ResearchDowngradeBuy -> NeutralN/AView Rating Details
9/22/2016ArgusReiterated RatingBuy$140.00N/AView Rating Details
8/23/2016BarclaysBoost Price TargetOverweight$140.00 -> $145.00N/AView Rating Details
7/29/2016JMP SecuritiesBoost Price TargetMarket Outperform$131.00 -> $145.00N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
3/17/2016NomuraInitiated CoverageBuy$123.00N/AView Rating Details
1/31/2016William BlairReiterated RatingOutperformN/AView Rating Details
1/29/2016Northland SecuritiesLower Price Target$109.00 -> $105.00N/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

Zimmer Biomet (NYSE:ZBH) Earnings History and Estimates Chart

Earnings by Quarter for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE ZBH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/29/2018N/AView Earnings Details
11/1/2017Q3 2017$1.74$1.72$1.83 billion$1.82 billionViewN/AView Earnings Details
7/27/2017Q2 2017$2.10$2.08$1.95 billion$1.95 billionViewN/AView Earnings Details
4/27/2017Q1 2017$2.11$2.13$1.96 billion$1.98 billionViewN/AView Earnings Details
1/31/2017Q416$2.11$2.14$1.98 billion$2.01 billionViewListenView Earnings Details
10/31/2016Q316$1.79$1.79$950.20 million$1.83 billionViewListenView Earnings Details
7/28/2016Q216$1.97$2.02$1.90 billion$1.93 billionViewListenView Earnings Details
4/28/2016Q116$1.93$2.00$1.88 billion$1.90 billionViewListenView Earnings Details
1/28/2016Q415$2.04$2.09$1.96 billion$1.98 billionViewListenView Earnings Details
10/29/2015Q315$1.56$1.64$1.76 billion$1.76 billionViewListenView Earnings Details
4/30/2015Q115$1.54$1.58$1.15 billion$1.13 billionViewN/AView Earnings Details
1/29/2015Q414$1.71$0.91$1.25 billion$1.22 billionViewN/AView Earnings Details
10/23/2014Q314$1.00$0.96$1.10 billion$1.11 billionViewListenView Earnings Details
7/24/2014Q214$1.49$1.49$1.21 billion$1.18 billionViewN/AView Earnings Details
4/24/2014Q114$1.47$1.50$1.18 billion$1.16 billionViewListenView Earnings Details
1/31/2014Q114$1.62$1.36$1.22 billion$1.24 billionViewN/AView Earnings Details
10/24/2013Q313$1.24$1.25$1.06 billion$1.07 billionViewN/AView Earnings Details
7/25/2013Q2 2013$1.44$1.43$1.15 billion$1.17 billionViewN/AView Earnings Details
4/25/2013Q1 2013$1.40$1.41$1.14 billion$1.14 billionViewN/AView Earnings Details
1/31/2013Q4 2012$1.49$1.51$1.17 billion$1.18 billionViewN/AView Earnings Details
10/25/2012$1.13$1.15ViewN/AView Earnings Details
7/26/2012$1.32$1.34ViewN/AView Earnings Details
4/26/2012$1.30$1.30ViewN/AView Earnings Details
1/26/2012$1.34$1.36ViewN/AView Earnings Details
10/27/2011$1.03$1.04ViewN/AView Earnings Details
7/27/2011$1.19$1.21ViewN/AView Earnings Details
4/28/2011$1.12$1.19ViewN/AView Earnings Details
1/27/2011$1.19$1.21ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Zimmer Biomet (NYSE:ZBH) Earnings Estimates

2017 EPS Consensus Estimate: $8.09
2018 EPS Consensus Estimate: $8.19
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$2.10$2.14$2.11
Q2 20176$2.08$2.18$2.12
Q3 20176$1.71$1.93$1.77
Q4 20176$2.08$2.11$2.10
Q1 20185$1.92$2.10$2.00
Q2 20185$1.97$2.14$2.02
Q3 20185$1.84$1.98$1.91
Q4 20185$2.23$2.29$2.26
(Data provided by Zacks Investment Research)

Dividends

Zimmer Biomet (NYSE:ZBH) Dividend Information

Most Recent Dividend:10/27/2017
Annual Dividend:$0.96
Dividend Yield:0.85%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:30.19% (Trailing 12 Months of Earnings)
11.96% (Based on This Year's Estimates)
11.68% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE:ZBH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/7/2017quarterly$0.240.83%9/21/20179/22/201710/27/2017
5/30/2017quarterly$0.240.81%6/21/20176/23/20177/28/2017
3/1/2017quarterly$0.240.81%3/29/20173/31/20174/28/2017
12/19/2016quarterly$0.240.94%12/28/201612/30/20161/27/2017
8/23/2016quarterly$0.240.74%9/21/20169/23/201610/28/2016
5/23/2016quarterly$0.246/22/20166/24/20167/29/2016
2/24/2016quarterly$0.240.99%3/29/20163/31/20164/29/2016
12/14/2015quarterly$0.220.87%12/29/201512/31/20151/29/2016
8/24/2015quarterly$0.220.9%9/28/20159/30/201510/30/2015
5/5/2015quarterly$0.220.8%5/13/20155/15/20157/14/2015
2/24/2015quarterly$0.220.73%3/4/20153/6/20154/24/2015
12/15/2014quarterly$0.220.81%12/24/201412/29/20141/30/2015
8/26/2014quarterly$0.220.87%9/24/20149/26/201410/31/2014
5/23/2014quarterly$0.220.86%6/25/20146/27/20147/25/2014
3/5/2014quarterly$0.220.9%3/26/20143/28/20144/25/2014
12/16/2013quarterly$0.200.88%12/24/201312/27/20131/31/2014
9/9/2013quarterly$0.200.99%9/25/20139/27/201310/25/2013
6/14/2013quarterly$0.201.03%6/26/20136/28/20137/26/2013
3/8/2013quarterly$0.201.06%3/26/20133/29/20134/26/2013
12/14/2012quarterly$0.181.06%12/24/201212/27/20121/25/2013
(Data available from 1/1/2013 forward)

Insider Trades

Zimmer Biomet (NYSE ZBH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.07%
Institutional Ownership Percentage: 86.24%
Insider Trades by Quarter for Zimmer Biomet (NYSE:ZBH)
Institutional Ownership by Quarter for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE ZBH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/31/2017Tony W. CollinsVPSell16,986$121.74$2,067,875.64View SEC Filing  
6/12/2017Sang YiInsiderSell17,731$124.56$2,208,573.36View SEC Filing  
5/5/2017Chad F. PhippsVPSell6,200$116.76$723,912.00View SEC Filing  
4/27/2017David C DvorakInsiderSell87,331$116.47$10,171,441.57View SEC Filing  
3/20/2017David C DvorakInsiderSell1,040$121.63$126,495.20View SEC Filing  
12/2/2016David A. Jr. NolanInsiderSell5,050$101.11$510,605.50View SEC Filing  
9/8/2016Daniel E WilliamsonInsiderSell2,716$129.96$352,971.36View SEC Filing  
8/23/2016Stuart G KleopferInsiderSell3,397$129.71$440,624.87View SEC Filing  
8/12/2016Tony W. CollinsVPSell1,287$129.16$166,228.92View SEC Filing  
8/9/2016Stuart G KleopferInsiderSell533$132.71$70,734.43View SEC Filing  
8/1/2016David A. Jr. NolanInsiderSell25,255$130.77$3,302,596.35View SEC Filing  
7/11/2016Daniel P FlorinCFOSell15,000$124.98$1,874,700.00View SEC Filing  
6/14/2016Tony W CollinsCAOSell3,611$116.43$420,428.73View SEC Filing  
6/9/2016Stuart G KleopferInsiderSell11,000$119.45$1,313,950.00View SEC Filing  
4/14/2016Daniel P FlorinCFOSell10,000$114.98$1,149,800.00View SEC Filing  
4/12/2016Daniel P FlorinCFOSell12,000$110.00$1,320,000.00View SEC Filing  
3/21/2016David C DvorakCEOSell1,540$104.16$160,406.40View SEC Filing  
2/10/2016Blackstone Capital Partners VMajor ShareholderSell7,351,708$95.91$705,102,314.28View SEC Filing  
1/8/2016David C. DvorakCEOSell44,661$102.46$4,575,966.06View SEC Filing  
12/2/2015David A. Jr. NolaninsiderSell3,435$102.62$352,499.70View SEC Filing  
6/30/2015Adam Rudolph JohnsonInsiderSell30,600$110.34$3,376,404.00View SEC Filing  
6/29/2015Daniel E WilliamsonInsiderSell16,000$110.98$1,775,680.00View SEC Filing  
6/29/2015Daniel P FlorinCFOSell5,000$107.00$535,000.00View SEC Filing  
3/17/2015David C DvorakCEOSell1,300$115.55$150,215.00View SEC Filing  
12/5/2014David C DvorakCEOSell48,703$115.00$5,600,845.00View SEC Filing  
11/28/2014Chad F PhippsVPSell5,000$112.00$560,000.00View SEC Filing  
11/3/2014Katarzyna Mazur-HofsaessInsiderSell28,253$110.01$3,108,112.53View SEC Filing  
9/9/2014Stephen Hong Liang OoiInsiderSell40,768$102.78$4,190,135.04View SEC Filing  
8/26/2014James T CrinesCFOSell40,768$101.00$4,117,568.00View SEC Filing  
1/8/2014Jeffery MccaulleyInsiderSell21,286$96.00$2,043,456.00View SEC Filing  
1/7/2014Chad PhippsVPSell7,000$95.00$665,000.00View SEC Filing  
12/20/2013Jeffery MccaulleyInsiderSell21,286$93.00$1,979,598.00View SEC Filing  
12/3/2013Jeffery MccaulleyInsiderSell2,713$90.12$244,495.56View SEC Filing  
11/15/2013Derek DavisCAOSell3,500$90.20$315,700.00View SEC Filing  
11/14/2013Chad PhippsVPSell7,800$90.00$702,000.00View SEC Filing  
11/14/2013David DvorakCEOSell64,763$90.00$5,828,670.00View SEC Filing  
11/14/2013Jeffery MccaulleyInsiderSell21,285$90.00$1,915,650.00View SEC Filing  
9/13/2013Katarzyna Mazur-HofsaessInsiderSell4,890$81.38$397,948.20View SEC Filing  
8/1/2013James T CrinesCFOSell46,200$84.56$3,906,672.00View SEC Filing  
8/1/2013Stephen Hong Liang OoiInsiderSell38,500$84.27$3,244,395.00View SEC Filing  
7/29/2013Derek M DavisCAOSell3,725$83.78$312,080.50View SEC Filing  
7/29/2013Jeffery A MccaulleyInsiderSell112,255$83.40$9,362,067.00View SEC Filing  
7/19/2013Chad F PhippsVPSell6,000$83.00$498,000.00View SEC Filing  
5/8/2013Chad F PhippsVPSell5,000$77.26$386,300.00View SEC Filing  
4/30/2013James T CrinesCFOSell25,000$76.08$1,902,000.00View SEC Filing  
4/30/2013Jeffery A MccaulleyInsiderSell10,000$76.08$760,800.00View SEC Filing  
2/4/2013Derek M DavisCAOSell21,864$72.53$1,585,795.92View SEC Filing  
2/4/2013Jeffery A MccaulleyInsiderSell12,000$73.60$883,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Zimmer Biomet (NYSE ZBH) News Headlines

Source:
DateHeadline
BMO Capital Markets Reaffirms "Buy" Rating for Zimmer Biomet (ZBH)BMO Capital Markets Reaffirms "Buy" Rating for Zimmer Biomet (ZBH)
www.americanbankingnews.com - December 12 at 8:38 PM
Zimmer Biomet Holdings Inc (ZBH) Given Average Recommendation of "Hold" by BrokeragesZimmer Biomet Holdings Inc (ZBH) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - December 11 at 5:56 AM
Stryker and Zimmer Biomet Holdings Settled a Trade Secret CaseStryker and Zimmer Biomet Holdings Settled a Trade Secret Case
finance.yahoo.com - December 5 at 12:15 PM
Zimmer Biomet Holdings, Inc. breached its 50 day moving average in a Bearish Manner : ZBH-US : December 4, 2017Zimmer Biomet Holdings, Inc. breached its 50 day moving average in a Bearish Manner : ZBH-US : December 4, 2017
finance.yahoo.com - December 4 at 10:30 AM
Zimmer Biomet (ZBH) Rating Lowered to C+ at TheStreetZimmer Biomet (ZBH) Rating Lowered to C+ at TheStreet
www.americanbankingnews.com - November 28 at 6:30 PM
ETFs with exposure to Zimmer Biomet Holdings, Inc. : November 27, 2017ETFs with exposure to Zimmer Biomet Holdings, Inc. : November 27, 2017
finance.yahoo.com - November 28 at 11:34 AM
$2.03 Billion in Sales Expected for Zimmer Biomet Holdings, Inc. (ZBH) This Quarter$2.03 Billion in Sales Expected for Zimmer Biomet Holdings, Inc. (ZBH) This Quarter
www.americanbankingnews.com - November 26 at 4:08 PM
Zimmer Biomet Holdings, Inc. (ZBH) Upgraded at Deutsche Bank AGZimmer Biomet Holdings, Inc. (ZBH) Upgraded at Deutsche Bank AG
www.americanbankingnews.com - November 25 at 6:50 PM
Zimmer Biomet Hurt by Supply Delay, Knee Challenges Remain - NasdaqZimmer Biomet Hurt by Supply Delay, Knee Challenges Remain - Nasdaq
www.nasdaq.com - November 24 at 8:12 AM
Zimmer Biomet to Present at 29th Annual Piper Jaffray Healthcare ConferenceZimmer Biomet to Present at 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 23 at 8:14 AM
Zimmer Biomet Holdings, Inc. :ZBH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 22, 2017Zimmer Biomet Holdings, Inc. :ZBH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 22, 2017
finance.yahoo.com - November 23 at 8:14 AM
Zacks Investment Research Lowers Zimmer Biomet Holdings, Inc. (ZBH) to Strong SellZacks Investment Research Lowers Zimmer Biomet Holdings, Inc. (ZBH) to Strong Sell
www.americanbankingnews.com - November 20 at 10:26 AM
What’s behind Zimmer Biomet’s Recent Stock Downtrend?What’s behind Zimmer Biomet’s Recent Stock Downtrend?
finance.yahoo.com - November 16 at 10:13 AM
Zimmer Biomet Holdings, Inc. (ZBH) Given Consensus Recommendation of "Hold" by BrokeragesZimmer Biomet Holdings, Inc. (ZBH) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 16 at 5:42 AM
Zimmer Biomet Lowered 2017 Guidance Again amid Major HeadwindsZimmer Biomet Lowered 2017 Guidance Again amid Major Headwinds
finance.yahoo.com - November 13 at 8:20 PM
Ankle Replacements Take Off as Devices Appear DurableAnkle Replacements Take Off as Devices Appear Durable
finance.yahoo.com - November 13 at 10:24 AM
Zimmer Biomet’s Plan to Revive Growth amid Supply DisruptionsZimmer Biomet’s Plan to Revive Growth amid Supply Disruptions
finance.yahoo.com - November 13 at 10:24 AM
Attractive Product Pipeline Could Revive Zimmer Biomet’s GrowthAttractive Product Pipeline Could Revive Zimmer Biomet’s Growth
finance.yahoo.com - November 13 at 10:24 AM
Key Launches Expected to Drive Zimmer Biomet’s SalesKey Launches Expected to Drive Zimmer Biomet’s Sales
finance.yahoo.com - November 12 at 1:46 PM
Asia-Pacific Still Zimmer Biomet’s Strongest GeographyAsia-Pacific Still Zimmer Biomet’s Strongest Geography
finance.yahoo.com - November 12 at 1:46 PM
Zimmer Biomet to Present at Jefferies 2017 London Healthcare ConferenceZimmer Biomet to Present at Jefferies 2017 London Healthcare Conference
finance.yahoo.com - November 9 at 10:47 AM
Q4 2017 EPS Estimates for Zimmer Biomet Holdings, Inc. Cut by Analyst (ZBH)Q4 2017 EPS Estimates for Zimmer Biomet Holdings, Inc. Cut by Analyst (ZBH)
www.americanbankingnews.com - November 8 at 12:50 PM
Zimmer Biomet Holdings, Inc.’s (ZBH) Upgraded to HoldZimmer Biomet Holdings, Inc.’s (ZBH) Upgraded to Hold
investorplace.com - November 7 at 4:18 PM
SunTrust Banks Equities Analysts Reduce Earnings Estimates for Zimmer Biomet Holdings, Inc. (ZBH)SunTrust Banks Equities Analysts Reduce Earnings Estimates for Zimmer Biomet Holdings, Inc. (ZBH)
www.americanbankingnews.com - November 7 at 5:52 AM
Zimmer Biomet Holdings, Inc. (ZBH) Stock Rating Lowered by Zacks Investment ResearchZimmer Biomet Holdings, Inc. (ZBH) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - November 6 at 2:54 PM
Analysts Issue Forecasts for Zimmer Biomet Holdings, Inc.s FY2019 Earnings (ZBH)Analysts Issue Forecasts for Zimmer Biomet Holdings, Inc.'s FY2019 Earnings (ZBH)
www.americanbankingnews.com - November 6 at 2:20 PM
FY2017 EPS Estimates for Zimmer Biomet Holdings, Inc. (ZBH) Cut by AnalystFY2017 EPS Estimates for Zimmer Biomet Holdings, Inc. (ZBH) Cut by Analyst
www.americanbankingnews.com - November 6 at 1:22 AM
Oppenheimer Holdings Analysts Cut Earnings Estimates for Zimmer Biomet Holdings, Inc. (ZBH)Oppenheimer Holdings Analysts Cut Earnings Estimates for Zimmer Biomet Holdings, Inc. (ZBH)
www.americanbankingnews.com - November 6 at 1:22 AM
Zimmer Biomet Holdings, Inc. (ZBH) Forecasted to Post FY2017 Earnings of $8.01 Per ShareZimmer Biomet Holdings, Inc. (ZBH) Forecasted to Post FY2017 Earnings of $8.01 Per Share
www.americanbankingnews.com - November 6 at 1:22 AM
Equities Analysts Set Expectations for Zimmer Biomet Holdings, Inc.s FY2017 Earnings (ZBH)Equities Analysts Set Expectations for Zimmer Biomet Holdings, Inc.'s FY2017 Earnings (ZBH)
www.americanbankingnews.com - November 6 at 1:22 AM
Research Analysts Issue Forecasts for Zimmer Biomet Holdings, Inc.s FY2017 Earnings (ZBH)Research Analysts Issue Forecasts for Zimmer Biomet Holdings, Inc.'s FY2017 Earnings (ZBH)
www.americanbankingnews.com - November 6 at 1:22 AM
Zimmer Biomet Holdings (ZBH) "Buy" Rating Reiterated at Jefferies Group LLCZimmer Biomet Holdings' (ZBH) "Buy" Rating Reiterated at Jefferies Group LLC
www.americanbankingnews.com - November 5 at 4:56 PM
Zimmer Biomet Holdings, Inc. – Value Analysis (NYSE:ZBH) : November 3, 2017Zimmer Biomet Holdings, Inc. – Value Analysis (NYSE:ZBH) : November 3, 2017
finance.yahoo.com - November 5 at 8:27 AM
Zimmer Biomet Holdings, Inc. (ZBH) Earns "Hold" Rating from Stifel NicolausZimmer Biomet Holdings, Inc. (ZBH) Earns "Hold" Rating from Stifel Nicolaus
www.americanbankingnews.com - November 3 at 5:14 PM
Zimmer Biomet Holdings, Inc. (ZBH) Price Target Cut to $135.00Zimmer Biomet Holdings, Inc. (ZBH) Price Target Cut to $135.00
www.americanbankingnews.com - November 2 at 6:28 PM
Morgan Stanley Cuts Zimmer Biomet Holdings, Inc. (ZBH) Price Target to $136.00Morgan Stanley Cuts Zimmer Biomet Holdings, Inc. (ZBH) Price Target to $136.00
www.americanbankingnews.com - November 2 at 6:28 PM
Zimmer Biomet Holdings (ZBH) Misses Q3 EPS by 4c, Miss on Revenues; Lowers FY17 EPS Guidance Below Consensus; FY17 Revenue Outlook Below ConsensusZimmer Biomet Holdings (ZBH) Misses Q3 EPS by 4c, Miss on Revenues; Lowers FY17 EPS Guidance Below Consensus; FY17 Revenue Outlook Below Consensus
www.streetinsider.com - November 2 at 11:59 AM
Edited Transcript of ZBH earnings conference call or presentation 1-Nov-17 12:00pm GMTEdited Transcript of ZBH earnings conference call or presentation 1-Nov-17 12:00pm GMT
finance.yahoo.com - November 2 at 11:59 AM
Estee Lauder, US Steel jump but Envision Healthcare tumblesEstee Lauder, US Steel jump but Envision Healthcare tumbles
finance.yahoo.com - November 2 at 11:58 AM
Zimmer Biomet Holdings, Inc. breached its 50 day moving average in a Bearish Manner : ZBH-US : November 2, 2017Zimmer Biomet Holdings, Inc. breached its 50 day moving average in a Bearish Manner : ZBH-US : November 2, 2017
finance.yahoo.com - November 2 at 11:58 AM
FY2017 EPS Estimates for Zimmer Biomet Holdings, Inc. Reduced by Jefferies Group (ZBH)FY2017 EPS Estimates for Zimmer Biomet Holdings, Inc. Reduced by Jefferies Group (ZBH)
www.americanbankingnews.com - November 2 at 6:48 AM
Zimmer Biomet Holdings, Inc. (ZBH) Given a $136.00 Price Target at SunTrust Banks, Inc.Zimmer Biomet Holdings, Inc. (ZBH) Given a $136.00 Price Target at SunTrust Banks, Inc.
www.americanbankingnews.com - November 1 at 3:22 PM
Zimmer Biomet Holdings, Inc. (ZBH) Announces  Earnings ResultsZimmer Biomet Holdings, Inc. (ZBH) Announces Earnings Results
www.americanbankingnews.com - November 1 at 11:36 AM
Zimmer Biomet Holdings, Inc. 2017 Q3 - Results - Earnings Call SlidesZimmer Biomet Holdings, Inc. 2017 Q3 - Results - Earnings Call Slides
seekingalpha.com - November 1 at 11:09 AM
Zimmer Biomets (ZBH) Q3 Earnings Lag Estimates, View DownZimmer Biomet's (ZBH) Q3 Earnings Lag Estimates, View Down
www.zacks.com - November 1 at 11:09 AM
Zimmer misses Street 3Q forecastsZimmer misses Street 3Q forecasts
finance.yahoo.com - November 1 at 11:08 AM
Zimmer Biomet (ZBH) Misses Q3 Earnings, Meets Sales EstimateZimmer Biomet (ZBH) Misses Q3 Earnings, Meets Sales Estimate
finance.yahoo.com - November 1 at 11:08 AM
Zimmer Biomet Holdings, Inc. (ZBH) Updates FY17 Earnings GuidanceZimmer Biomet Holdings, Inc. (ZBH) Updates FY17 Earnings Guidance
www.americanbankingnews.com - November 1 at 9:47 AM
Zimmer Biomet Holdings, Inc. (ZBH) Issues Q4 Earnings GuidanceZimmer Biomet Holdings, Inc. (ZBH) Issues Q4 Earnings Guidance
www.americanbankingnews.com - November 1 at 9:37 AM
Shrinking Industry Group Rank Makes Zimmer Biomet Holdings, Inc. (ZBH) a SellShrinking Industry Group Rank Makes Zimmer Biomet Holdings, Inc. (ZBH) a Sell
investorplace.com - October 31 at 11:57 AM

SEC Filings

Zimmer Biomet (NYSE:ZBH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Zimmer Biomet (NYSE:ZBH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Zimmer Biomet (NYSE ZBH) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.